Wednesday, March 6, 2024

CanBio Bagel Talk

9:00 AM to 10:00 AM

Hybrid meeting:
In-person at the Rogel Cancer Center, room 3206
or virtual Zoom meeting

Contact Kurt Nelson

Join the Zoom meeting. 

Meeting ID: 935 3982 3315. Passcode: bageltalk

Ranjit Mehta, PhD from the Nyati lab

Speaking on: Overcoming Radiation Resistance in Brain Tumors: A Novel Combination Therapy using DPI-503 and xCT Inhibition.

Ranjit Kumar Mehta

Ranjit Mehta, PhD

Research Laboratory Specialist

Ranjit received his doctorate from the School of Biotechnology, KIIT University, India. He primarily worked on methods to improve therapeutic properties of L-Asparaginase for the treatment of acute lymphoblastic leukemia. Dr. Mehta joined the Nyati Lab as a post-doctoral fellow in May of 2015. He is working on several research projects ranging from understanding the roles of Hsp90 alpha in response to DNA damage/repair to developing a novel approach to blocking EGFR dimer formation to destabilize EGFR protein as a unique approach to kill EGFR driven cancer cells. Dr. Mehta is also supervising all the students in Nyati laboratory.